Are there new therapies under research for APS Type 1? 
 Executive Summary Autoimmune Polyglandular Syndrome Type 1 Market Opportunities by Size and Share
Data Bridge Market Research analyses that the autoimmune polyglandular syndrome type 1 market was valued at USD 228 million in 2021 and is expected to reach USD 347.26 million by 2029, registering a CAGR of 5.40% during the forecast period of 2022 to 2029.
An international Autoimmune Polyglandular...
     0 Comentários
               0 Compartilhamentos
              
  
  
  
  English
English
             Arabic
Arabic
             French
French
             Spanish
Spanish
             Portuguese
Portuguese
             Deutsch
Deutsch
             Turkish
Turkish
             Dutch
Dutch
             Italiano
Italiano
             Russian
Russian
             Romaian
Romaian
             Greek
Greek